Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
about
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryNew Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) NanoparticlesCpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa.Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.Recent advances of chitosan nanoparticles as drug carriersHepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice.Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection.H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice.Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.Initial observations of cell-mediated drug delivery to the deep lungPolymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for ostholePotential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune ResponsesThe application of mucoadhesive polymers in nasal drug delivery.Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting.Nanoparticulate drug delivery systems for cancer chemotherapy.A review on mucoadhesive polymer used in nasal drug delivery system.Nanomedicine in cardiovascular therapy: recent advancements.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery.Pharmaceutical applications of the Calu-3 lung epithelia cell line.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationResveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery systemIntranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.Lecithin/chitosan nanoparticles for transdermal delivery of melatonin.Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses.Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.Glucose-sensitive polyelectrolyte nanocapsules based on layer-by-layer technique for protein drug delivery.
P2860
Q26766552-684E961D-6A4D-4A1C-B0C0-B9D28D6C9474Q28546279-3525AD15-03FB-4661-BAEA-8C96171689E2Q30373064-E066E3B9-74A9-46AF-8E57-B4CBD39DE135Q30869313-43BEC59B-A857-4252-9899-91F2251AFAE0Q33414140-F4DEBF82-8F15-432E-9906-64E5622FE23AQ34956317-CF7D5D35-EAAA-432F-99CF-0949D705A339Q35025219-89ACD658-7237-41B2-B38D-36AB26BD7387Q35143516-19C433A1-3CE8-4184-9631-6D194F0B3A3CQ35221169-391C64BB-2A4A-4D69-884C-E0A4408DF014Q35556928-755C5704-6B10-4B6D-802C-89AD9A00CC54Q35884617-00709B3E-6871-4341-86E4-EA9EF7371E8DQ36316919-E18A1A57-0CBB-4BF5-805C-76923ED520D4Q36502198-B4DE3858-70AA-4CCA-9E3C-024D8B251C77Q37219116-FDF598BC-2960-4FA1-B1E0-F89124B82B21Q37248835-C13A75AD-7CB6-4D98-9523-521CE0E0C4C4Q37255405-B09A4110-DF4D-49B4-A74B-463506FECADAQ37293872-EF44E30E-0221-4768-B931-DBDD97D6D22AQ37593083-80643AED-E6DF-436E-99E8-1226C268C558Q37693763-D5D49D58-0EDD-45B4-B60A-9DCB1FEBB5BCQ37766235-C7843A55-D385-4DDD-96AE-F353DD4E2C6BQ37772516-BB62EF69-98D1-4639-A85A-EC7154CBDF12Q37799616-8F8DD7D4-6855-42C4-8D1B-6F6EDC3B7D81Q37976082-533336F8-A8CE-4B5B-948E-14F91487C4B5Q38034812-3F98CD34-7EB9-4F9F-A37F-F3758693E915Q38067265-365D9744-8377-4722-886A-FFFF49197CCEQ38069606-A616D1F0-C57B-4501-B4F1-9B9B976E7030Q38111427-2496D084-D4C5-4BCC-8A74-F42B8D52D67CQ38195730-AB855BB8-AD63-4CA3-AED8-C631F50F274BQ38634048-106D748E-3F0D-450A-9790-8B9144810D82Q38731185-0711BDBB-5F19-4941-ABE9-6D844A3B6D1BQ38809370-C16AA927-0E23-4DB8-A2E4-BAD3312E405BQ38826782-C518CA5C-315F-4A1D-83FD-AA7473C87406Q38879581-F7D081D9-A7AF-45F7-A55C-90F016F44D5BQ39084200-05283F0F-8615-4CA8-9F10-AA0467BC7CB9Q39121416-A3C7DD57-3338-49F7-B69C-A4E08A06319DQ39437287-64D35368-CC14-4218-AEC7-DBC5EAE23135Q39495849-DFBF16B2-A52D-4F67-9725-BB40058B78BAQ39643834-539B0DEC-F417-4210-B05A-209C2067900CQ39758165-03038693-9EE8-4A06-8C4A-0FB5B060BD96Q42812867-D903F0B1-8390-442E-AC8A-4484830B2B29
P2860
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Preparation and characterizati ...... cles as nasal delivery system.
@ast
Preparation and characterizati ...... cles as nasal delivery system.
@en
type
label
Preparation and characterizati ...... cles as nasal delivery system.
@ast
Preparation and characterizati ...... cles as nasal delivery system.
@en
prefLabel
Preparation and characterizati ...... cles as nasal delivery system.
@ast
Preparation and characterizati ...... cles as nasal delivery system.
@en
P2093
P1476
Preparation and characterizati ...... cles as nasal delivery system.
@en
P2093
Gerrit Borchard
Hans E Junginger
Maryam Amidi
Stefan G Romeijn
Wim E Hennink
Wim Jiskoot
P304
P356
10.1016/J.JCONREL.2005.11.014
P407
P577
2005-12-27T00:00:00Z